154 - Taking Care of Business: Funding Drug Discovery through the SBIR/STTR Programs

Session Chair(s)

• Stephanie Davis

  Speaker
  National Institutes of Health

The Small Business Innovation Research (SBIR) and Small Business Tech Transfer (STTR) programs are congressionally-mandated programs that allow federal agencies to fund promising technologies that fulfill their missions. SBIR/STTR grants through the NIH and NSF are a valuable resource to academic pharmacologists and early-stage entrepreneurs looking to bring their new therapeutics to the market. This panel will feature NIH and NSF program staff, SBIR/STTR awardees, and reviewers who have served on SBIR/STTR study sections and provide information for pharmacologists who are interested in pursuing these opportunities.

Presentations:

• 2:00 PM – 2:05 PM

  Introduction
• 2:05 PM – 2:20 PM

  Funding the Development of Therapeutics through the NIH SBIR/STTR Program
  

  Speaker: Stephanie Davis – National Institutes of Health
• 2:20 PM – 2:35 PM

  Overseeing the Process of Small Business Grant Review
  

  Speaker: Mary-Ann Bjornsti – University of Alabama at Birmingham
• 2:35 PM – 2:50 PM

  Shining Light on the Dark Side
  

  Speaker: Elizabeth Sharlow – University of Virginia/KeViRx
• 2:50 PM – 3:05 PM

  Lessons Learned from Successes and Failures of SBIR/STTR Grants
  

  Speaker: Harshini Neelakantan – Ridgeline Therapeutics
• 3:05 PM – 3:30 PM

  Moderated Q&A